| 10001 | KLRF1 levels | GCST90469712 | 0.03 |
| 10002 | aparc-DKTatlas rh thickness lingual | GCST90003582 | 0.03 |
| 10003 | LRIG3 levels | GCST90469795 | 0.03 |
| 10004 | Multi-site chronic pain | Other trait | UKBB00000490 | 0.03 |
| 10005 | IDP dMRI ProbtrackX OD slf r | GCST90004472 | 0.03 |
| 10006 | PDGFA/SNAP23 ratio | GCST90315619 | 0.03 |
| 10007 | Principal component-derived dietary pattern 1 | GCST90133006 | 0.03 |
| 10008 | F-cooking flavour liking (derived food-liking factor) | GCST90094742 | 0.03 |
| 10009 | Spermatocele | FING00001319 | 0.03 |
| 10010 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T178 | ECGA000178 | 0.03 |
| 10011 | Chronic obstructive pulmonary disease in never smokers | GCST90016589 | 0.03 |
| 10012 | F-sharp flavour liking (derived food-liking factor) | GCST90094837 | 0.03 |
| 10013 | SCGB3A1 levels | GCST90470542 | 0.03 |
| 10014 | EDAR/SNAP23 ratio | GCST90314587 | 0.03 |
| 10015 | Alcohol-induced chronic pancreatitis | FING00000055 | 0.03 |
| 10016 | Asthma | GCST90014325 | 0.03 |
| 10017 | ARHGAP25/RNF41 ratio | GCST90313345 | 0.03 |
| 10018 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T281 | ECGA000281 | 0.03 |
| 10019 | Milk chocolate liking | GCST90094801 | 0.03 |
| 10020 | Weight (maximum, inv-normal transformed) | GCST90476460 | 0.03 |
| 10021 | Lymphoid neoplasms | GCST90624743 | 0.03 |
| 10022 | SIGLEC8 levels | GCST90089886 | 0.03 |
| 10023 | CDCP1/IL18BP ratio | GCST90313937 | 0.03 |
| 10024 | Illnesses of father - None of the above (group 2) | Family history | UKBB00000346 | 0.03 |
| 10025 | GALNT10/TNFSF12 ratio | GCST90314916 | 0.03 |
| 10026 | Diseases of sebaceous glands (PheCode 706) | GCST90476210 | 0.03 |
| 10027 | Osteopathies and chondropathies | FING00000913 | 0.03 |
| 10028 | CAG-269 sp001915995 abundance in stool | GCST90032266 | 0.03 |
| 10029 | MAP2 levels | GCST90469853 | 0.03 |
| 10030 | KIFBP/TACC3 ratio | GCST90315249 | 0.03 |
| 10031 | Sensitivity / hurt feelings | Mental health | UKBB00000766 | 0.03 |
| 10032 | Urine adenosine levels in chronic kidney disease | GCST90264757 | 0.03 |
| 10033 | Free cholesterol levels in IDL | GCST90092835 | 0.03 |
| 10034 | ICD10 O42: Premature rupture of membranes | GCST90454238 | 0.03 |
| 10035 | Other serious medical condition/disability diagnosed by doctor | Medical conditions | UKBB00000619 | 0.03 |
| 10036 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90092943 | 0.03 |
| 10037 | DCTN1/TRIAP1 ratio | GCST90314434 | 0.03 |
| 10038 | PRND levels | GCST90470333 | 0.03 |
| 10039 | Waist circumference | Body size measures | UKBB00000904 | 0.03 |
| 10040 | ICA1/YTHDF3 ratio | GCST90315113 | 0.03 |
| 10041 | PLXNA4/VASH1 ratio | GCST90315691 | 0.03 |
| 10042 | Monounsaturated fatty acid levels | GCST90502362 | 0.03 |
| 10043 | Type 1 diabetes with ketoacidosis (PheCode 250.11) | GCST90475662 | 0.03 |
| 10044 | Glucose levels (UKB data field 30740) | GCST90468071 | 0.03 |
| 10045 | Omega-6 fatty acids levels (UKB data field 23445) | GCST90269542 | 0.03 |
| 10046 | Ever unenthusiastic/disinterested for a whole week | Mental health | UKBB00000226 | 0.03 |
| 10047 | F-vegetarian liking (derived food-liking factor) | GCST90094863 | 0.03 |
| 10048 | Operative procedures - Injection of therapeutic substance into joint | Summary Operations | UKBB00000582 | 0.03 |
| 10049 | Vegetables liking | GCST90094862 | 0.03 |
| 10050 | CDH2 levels | GCST90468673 | 0.03 |
| 10051 | Haemoglobin concentration (UKB data field 30020) | GCST90468074 | 0.03 |
| 10052 | ICD10 O24.4: Diabetes mellitus arising in pregnancy | GCST90454236 | 0.03 |
| 10053 | CD209/CLEC4G ratio | GCST90313750 | 0.03 |
| 10054 | Qualifications - Other professional qualifications eg: nursing, teaching | Education | UKBB00000732 | 0.03 |
| 10055 | PHOSPHO1 levels | GCST90470227 | 0.03 |
| 10056 | CCL3 levels | GCST90012055 | 0.03 |
| 10057 | Triglyceride levels in medium LDL | GCST90092914 | 0.03 |
| 10058 | Body mass index (BMI, maximum, inv-normal transformed) | GCST90475153 | 0.03 |
| 10059 | Type 2 diabetes, wide definition | FING00001383 | 0.03 |
| 10060 | IRAK4/VASH1 ratio | GCST90315201 | 0.03 |
| 10061 | Type1 diabetes, definitions combined, early onset | FING00001384 | 0.03 |
| 10062 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T176 | ECGA000176 | 0.03 |
| 10063 | Body mass index | GCST90018727 | 0.03 |
| 10064 | FUT8/SORT1 ratio | GCST90314892 | 0.03 |
| 10065 | HEXIM1/NT5C3A ratio | GCST90315048 | 0.03 |
| 10066 | Left-hemisphere control network to amygdala white-matter structural connectivity | GCST90302757 | 0.03 |
| 10067 | Current employment status - Retired | Employment | UKBB00000159 | 0.03 |
| 10068 | CTRB1 levels | GCST90468905 | 0.03 |
| 10069 | X-24544 levels | GCST90200636 | 0.03 |
| 10070 | Parental longevity (mother's attained age) | GCST006696 | 0.03 |
| 10071 | DTI autoptx MD ptr r tract | GCST90385240 | 0.03 |
| 10072 | FADD/PLIN3 ratio | GCST90314772 | 0.03 |
| 10073 | CASP3/SNAP23 ratio | GCST90313644 | 0.03 |
| 10074 | Cereal consumption (bowls per week) (UKB data field 1458) | GCST90132982 | 0.03 |
| 10075 | Other peripheral vertigo | FING00001088 | 0.03 |
| 10076 | F9/RARRES2 ratio | GCST90314749 | 0.03 |
| 10077 | Principal component-derived dietary pattern 8 | GCST90133013 | 0.02 |
| 10078 | ALCAM/NOTCH1 ratio | GCST90313241 | 0.02 |
| 10079 | Blood urea nitrogen (BUN, minimum, inv-norm transformed) | GCST90475168 | 0.02 |
| 10080 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475460 | 0.02 |
| 10081 | Pure hypercholesterolaemia | FING00001230 | 0.02 |
| 10082 | Nontoxic multinodular goitre | FING00000888 | 0.02 |
| 10083 | OPTC levels | GCST90470128 | 0.02 |
| 10084 | aparc-Desikan rh area precentral | GCST90003130 | 0.02 |
| 10085 | GZMA levels | GCST90241323 | 0.02 |
| 10086 | MMP8/TGFA ratio | GCST90315466 | 0.02 |
| 10087 | Lysophosphatidylcholine (26:0) [sn2] levels | GCST90024189 | 0.02 |
| 10088 | aparc-Desikan lh volume precuneus | GCST90002792 | 0.02 |
| 10089 | Phenylacetylglutamate levels | GCST90200069 | 0.02 |
| 10090 | Triglyceride levels in very large HDL | GCST90093014 | 0.02 |
| 10091 | Cholesterol levels in medium LDL | GCST90092904 | 0.02 |
| 10092 | LDL direct, adjusted by medication | Lipid or lipoprotein measurement | UKBB00000387 | 0.02 |
| 10093 | Linoleic acid levels | GCST90502004 | 0.02 |
| 10094 | TREH levels | GCST90470959 | 0.02 |
| 10095 | DTI TBSS L2 Genu of corpus callosum | GCST90384478 | 0.02 |
| 10096 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T479 | ECGA000479 | 0.02 |
| 10097 | Tea consumption | GCST90096926 | 0.02 |
| 10098 | CST7 levels | GCST90468897 | 0.02 |
| 10099 | Saturated fatty acids levels (UKB data field 23448) | GCST90269545 | 0.02 |
| 10100 | NMNAT1 levels | GCST90470057 | 0.02 |
| 10101 | Omega-3 fatty acids levels | GCST90499139 | 0.02 |
| 10102 | FOLR2/HAVCR2 ratio | GCST90314865 | 0.02 |
| 10103 | Primary biliary cholangitis | GCST003129 | 0.02 |
| 10104 | ICAM1/REG1A ratio | GCST90315114 | 0.02 |
| 10105 | Clonal haematopoiesis of indeterminate potential (DNMT3A mutation) | GCST90165271 | 0.02 |
| 10106 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T244 | ECGU000244 | 0.02 |
| 10107 | Cholesteryl Esters in LDL | GCST90498374 | 0.02 |
| 10108 | MLN levels | GCST90469913 | 0.02 |
| 10109 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T177 | ECGA000177 | 0.02 |
| 10110 | PDGFB/ST6GAL1 ratio | GCST90315630 | 0.02 |
| 10111 | Psoriasis | GCST90468147 | 0.02 |
| 10112 | rfMRI connectivity (ICA100 edge 605) | GCST90005458 | 0.02 |
| 10113 | Other disorders of the musculoskeletal system and connective tissue | FING00001038 | 0.02 |
| 10114 | GOLM2/STC1 ratio | GCST90314952 | 0.02 |
| 10115 | General happiness | Happiness and subjective well-being | UKBB00000280 | 0.02 |
| 10116 | Total Phosphatidylethanolamine levels | GCST90025207 | 0.02 |
| 10117 | GLO1 levels | GCST90469358 | 0.02 |
| 10118 | Principal component-derived dietary pattern 45 | GCST90133050 | 0.02 |
| 10119 | Tobacco use disorder | mental disorders | UKBB00000824 | 0.02 |
| 10120 | VCAM1 levels | GCST90243317 | 0.02 |
| 10121 | Phospholipid levels in small VLDL | GCST90092976 | 0.02 |
| 10122 | STK11/USP8 ratio | GCST90315892 | 0.02 |
| 10123 | Administrative and legal statuses - NHS patient: not formally detained | Summary Administration | UKBB00000012 | 0.02 |
| 10124 | APP/BIN2 ratio | GCST90313316 | 0.02 |
| 10125 | Bipolar disorder | GCST003724 | 0.02 |
| 10126 | DTI autoptx L1 fmi tract | GCST90385150 | 0.02 |
| 10127 | NOTCH1/TIE1 ratio | GCST90315546 | 0.02 |
| 10128 | Acetone levels | GCST90092805 | 0.02 |
| 10129 | Childhood sunburn occasions | Sun exposure | UKBB00000130 | 0.02 |
| 10130 | PRRT3 levels | GCST90470340 | 0.02 |
| 10131 | Word interpolation | Fluid intelligence / reasoning | UKBB00000918 | 0.02 |
| 10132 | Bicarbonate (minimum, inv-norm transformed) | GCST90475150 | 0.02 |
| 10133 | ADAM23 levels | GCST90240922 | 0.02 |
| 10134 | Number of puzzles correctly solved (baseline) | GCST90565840 | 0.02 |
| 10135 | Nap during day | Sleep | UKBB00000492 | 0.02 |
| 10136 | Father's age at death | Family history | UKBB00000241 | 0.02 |
| 10137 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T476 | ECGA000476 | 0.02 |
| 10138 | Phosphatidylcholine acyl-alkyl C36:4 levels | GCST90240072 | 0.02 |
| 10139 | Length of working week for main job | Employment | UKBB00000405 | 0.02 |
| 10140 | Placental weight (paternal genotype, adjusted for sex) | GCST90275199 | 0.02 |
| 10141 | FADD/NFATC1 ratio | GCST90314771 | 0.02 |
| 10142 | CTRC levels | GCST90468906 | 0.02 |
| 10143 | Polyunsaturated fatty acid levels | GCST90502606 | 0.02 |
| 10144 | Other specified diseases of sebaceous glands (PheCode 706.8) | GCST90476215 | 0.02 |
| 10145 | ANGPT1/MPIG6B ratio | GCST90313265 | 0.02 |
| 10146 | aparc-Desikan rh thickness lingual | GCST90003491 | 0.02 |
| 10147 | Number of diet questionnaires completed | Diet questionnaire performance | UKBB00000536 | 0.02 |
| 10148 | CD79B/TNFRSF13B ratio | GCST90313902 | 0.02 |
| 10149 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T425 | ECGU000425 | 0.02 |
| 10150 | aparc-DKTatlas lh volume precuneus | GCST90002885 | 0.02 |
| 10151 | DTI TBSS L1 Superior longitudinal fasciculus L | GCST90384469 | 0.02 |
| 10152 | Cholesteryl Esters in Large LDL | GCST90497955 | 0.02 |
| 10153 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T283 | ECGA000283 | 0.02 |
| 10154 | Chronic obstructive pulmonary disease x ever smoker interaction (main effect) | GCST90016586 | 0.02 |
| 10155 | CNTN3/NCS1 ratio | GCST90314165 | 0.02 |
| 10156 | Other noninflammatory disorders of uterus, except cervix | FING00001079 | 0.02 |
| 10157 | Lysophosphatidylcholine (24:0) [sn2] levels | GCST90024187 | 0.02 |
| 10158 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T457 | ECGU000457 | 0.02 |
| 10159 | LHPP levels | GCST90469768 | 0.02 |
| 10160 | Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2) | GCST90476004 | 0.02 |
| 10161 | Mean platelet thrombocyte volume (UKB data field 30100) | GCST90468087 | 0.02 |
| 10162 | Whiskey liking | GCST90094873 | 0.02 |
| 10163 | CD300C/LRRC25 ratio | GCST90313790 | 0.02 |
| 10164 | Disorders of lacrimal system | FING00000441 | 0.02 |
| 10165 | Concentration of LDL particles | GCST90498413 | 0.02 |
| 10166 | Medication for pain relief, constipation, heartburn - Aspirin | Medication | UKBB00000454 | 0.02 |
| 10167 | Venous thromboembolism | GCST90399744 | 0.02 |
| 10168 | MME/NT5E ratio | GCST90315460 | 0.02 |
| 10169 | Other non-epithelial cancer of skin (PheCode 172.2) | GCST90475580 | 0.02 |
| 10170 | aparc-Desikan lh area parstriangularis | GCST90003092 | 0.02 |
| 10171 | CPA1 levels | GCST90468836 | 0.02 |
| 10172 | Basal cell carcinoma (PheCode 172.21) | GCST90475582 | 0.02 |
| 10173 | Omega-6 fatty acid levels | GCST90092933 | 0.02 |
| 10174 | CD46/NID1 ratio | GCST90313833 | 0.02 |
| 10175 | Linoleic acid levels (UKB data field 23449) | GCST90269546 | 0.02 |
| 10176 | Chronic obstructive pulmonary disease in non-current smokers | GCST90016594 | 0.02 |
| 10177 | FYB1/PDGFB ratio | GCST90314912 | 0.02 |
| 10178 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T211 | ECGU000211 | 0.02 |
| 10179 | DTI autoptx L1 ifo r tract | GCST90385152 | 0.02 |
| 10180 | SLAMF8 levels | GCST90470652 | 0.02 |
| 10181 | Age when finished full-time education (weighted GWA) | GCST90267281 | 0.02 |
| 10182 | CPB1 levels | GCST90468839 | 0.02 |
| 10183 | EPHB4 levels | GCST90469132 | 0.02 |
| 10184 | aparc-Desikan lh area postcentral | GCST90003094 | 0.02 |
| 10185 | aparc-Desikan lh area fusiform | GCST90003079 | 0.02 |
| 10186 | CD209/ITGAV ratio | GCST90313753 | 0.02 |
| 10187 | CASP3/CRKL ratio | GCST90313631 | 0.02 |
| 10188 | aparc-a2009s lh volume S-intrapariet+P-trans | GCST90002980 | 0.02 |
| 10189 | Risk taking (standard GWA) | GCST90267298 | 0.02 |
| 10190 | KIRREL2 levels | GCST90469690 | 0.02 |
| 10191 | Total esterified cholesterol levels | GCST90500036 | 0.02 |
| 10192 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T458 | ECGA000458 | 0.02 |
| 10193 | Phospholipids to total lipids in large HDL percentage (UKB data field 23634) | GCST90269731 | 0.02 |
| 10194 | Types of physical activity in last 4 weeks - Strenuous sports | Physical activity | UKBB00000874 | 0.02 |
| 10195 | Cholesterol levels in small LDL | GCST90092956 | 0.02 |
| 10196 | OGFR levels | GCST90470118 | 0.02 |
| 10197 | F-strong flavour liking (derived food-liking factor) | GCST90094851 | 0.02 |
| 10198 | Shellfish liking | GCST90094838 | 0.02 |
| 10199 | Longitudinal peak diastolic strain rate | GCST90019013 | 0.02 |
| 10200 | ThalamNuclei lh volume Pf | GCST90002722 | 0.02 |
| 10201 | Sleep duration | Sleep | UKBB00000777 | 0.02 |
| 10202 | ANG/RARRES2 ratio | GCST90313271 | 0.02 |
| 10203 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T282 | ECGA000282 | 0.02 |
| 10204 | LDL direct, adjusted by medication | Lipid or lipoprotein measurement | UKBB00000388 | 0.02 |
| 10205 | CALCOCO1/INPPL1 ratio | GCST90313603 | 0.02 |
| 10206 | Calculus of ureter (PheCode 594.3) | GCST90476147 | 0.02 |
| 10207 | CEP85/ZBTB16 ratio | GCST90314026 | 0.02 |
| 10208 | T1 FreeSurfer a2009s rh S temporal sup volume | GCST90385110 | 0.02 |
| 10209 | Free cholesterol levels in IDL | GCST90132676 | 0.02 |
| 10210 | Fracture of lumbar spine and pelvis | FING00000556 | 0.02 |
| 10211 | Own or rent accommodation lived in - Rent - from local authority, local council, housing association | Household | UKBB00000624 | 0.02 |
| 10212 | Prostate cancer | GCST90475185 | 0.02 |
| 10213 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475458 | 0.02 |
| 10214 | Spirits liking | GCST90094848 | 0.02 |
| 10215 | T1 CAT volume L TemporalOccipitalFusiformCortex | GCST90384076 | 0.02 |
| 10216 | Immature fraction of reticulocytes | GCST90002387 | 0.02 |
| 10217 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T180 | ECGA000180 | 0.02 |
| 10218 | Pain type(s) experienced in last month - None of the above | Pain | UKBB00000631 | 0.02 |
| 10219 | Cholesteryl esters to total lipids in small VLDL percentage (UKB data field 23601) | GCST90269698 | 0.02 |
| 10220 | Dronedarone medication | FING00000474 | 0.02 |
| 10221 | Participation in an health questionnaire (not invited vs invited) | GCST90012794 | 0.02 |
| 10222 | SFTPA2 levels | GCST90470613 | 0.02 |
| 10223 | Hemoglobin A1c levels | GCST90018738 | 0.02 |
| 10224 | Coffee type - Ground coffee (include espresso, filter etc) | Diet | UKBB00000140 | 0.02 |
| 10225 | LBR/PSRC1 ratio | GCST90315300 | 0.02 |
| 10226 | WWP2 levels | GCST90471080 | 0.02 |
| 10227 | T1 FreeSurfer DK rh supramarginal volume | GCST90385787 | 0.02 |
| 10228 | Diacylglycerol_34:0_[M+H-H2O]1+ levels | GCST90060181 | 0.02 |
| 10229 | Inflammatory markers and poor diet (confirmatory factor analysis Factor 30) | GCST90309364 | 0.02 |
| 10230 | SEMA3G levels | GCST90470571 | 0.02 |
| 10231 | RARRES2/TFPI ratio | GCST90315760 | 0.02 |
| 10232 | Sphingomyelin_32:1_[M+H]1+ levels | GCST90060225 | 0.02 |
| 10233 | Addison's disease | GCST90011871 | 0.02 |
| 10234 | Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers) | FING00000143 | 0.02 |
| 10235 | 1-palmitoylglycerophosphoethanolamine levels | GCST90243835 | 0.02 |
| 10236 | Gamma glutamyl transpeptidase | GCST90018734 | 0.02 |
| 10237 | Orotidine levels | GCST90200681 | 0.02 |
| 10238 | Chronic obstructive pulmonary disease x current smoker interaction (main effect) | GCST90016591 | 0.02 |
| 10239 | Processed meat consumption | GCST90132995 | 0.02 |
| 10240 | All dysplastic lesions of the cervix uteri | FING00000060 | 0.02 |
| 10241 | Body-mass index, inverse-rank normalized | FING00000222 | 0.02 |
| 10242 | Total phospholipid levels in lipoprotein particles | GCST90500124 | 0.02 |
| 10243 | CXCL16 levels | GCST90468928 | 0.02 |
| 10244 | EDA2R levels | GCST90469067 | 0.02 |
| 10245 | ThalamNuclei rh volume VLp | GCST90002755 | 0.02 |
| 10246 | potassium (maximum, inv-norm transformed) | GCST90476304 | 0.02 |
| 10247 | FKBP4/SIRT2 ratio | GCST90314841 | 0.02 |
| 10248 | TNFRSF13B levels | GCST90470905 | 0.02 |
| 10249 | Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified | FING00000432 | 0.02 |
| 10250 | TNFSF13B levels | GCST90470920 | 0.02 |
| 10251 | Platelet distribution width | Blood count | UKBB00000648 | 0.02 |
| 10252 | Comfortable retirement (confirmatory factor analysis Factor 29) | GCST90309363 | 0.02 |
| 10253 | Principal component-derived dietary pattern 19 | GCST90133024 | 0.02 |
| 10254 | T1 FreeSurfer DKT rh supramarginal volume | GCST90384377 | 0.02 |
| 10255 | HMBS/PSMG3 ratio | GCST90315064 | 0.02 |
| 10256 | SUGT1/TBL1X ratio | GCST90315897 | 0.02 |
| 10257 | PSMD9/UBAC1 ratio | GCST90315735 | 0.02 |
| 10258 | FAS levels | GCST90469192 | 0.02 |
| 10259 | Prostate cancer | GCST006085 | 0.02 |
| 10260 | Asparagine levels | GCST90243758 | 0.02 |
| 10261 | Cholesterol, total | GCST002221 | 0.02 |
| 10262 | Alanine aminotransferase levels | GCST90018723 | 0.02 |
| 10263 | EIF4G1/FKBP5 ratio | GCST90314633 | 0.02 |
| 10264 | Total cholesterol levels in HDL | GCST90132681 | 0.02 |
| 10265 | Methods of admission to hospital (recoded) - Elective admission: Booked | Summary Administration | UKBB00000461 | 0.02 |
| 10266 | HIP1R levels | GCST90469453 | 0.02 |
| 10267 | Neutrophil percentage of white cells | GCST004633 | 0.02 |
| 10268 | NAGA levels | GCST90469994 | 0.02 |
| 10269 | Mean corpuscular hemoglobin concentration | GCST90002329 | 0.02 |
| 10270 | Cholecystitis | FING00000274 | 0.02 |
| 10271 | FLT1/VEGFA ratio | GCST90314858 | 0.02 |
| 10272 | Daytime nap | GCST011494 | 0.02 |
| 10273 | CLEC1B/LBR ratio | GCST90314095 | 0.02 |
| 10274 | GIPC2 levels | GCST90469347 | 0.02 |
| 10275 | Mean corpuscular haemoglobin concentration | Blood count | UKBB00000448 | 0.02 |
| 10276 | Gestational age at birth (maternal effect) | GCST90268419 | 0.02 |
| 10277 | Omega-6 fatty acids to total fatty acids percentage | GCST90499210 | 0.02 |
| 10278 | MED18/ZBTB16 ratio | GCST90315416 | 0.02 |
| 10279 | Basal cell carcinoma, excluding all cancers (controls excluding all cancers) | FING00000142 | 0.02 |
| 10280 | CD164/CD99 ratio | GCST90313740 | 0.02 |
| 10281 | TST levels | GCST90470982 | 0.02 |
| 10282 | Prevotellamassilia abundance in stool | GCST90032517 | 0.02 |
| 10283 | Tea intake (UKB data field 1488) | GCST90132983 | 0.02 |
| 10284 | Fatty acid(20:3)_[M-H]1- levels | GCST90060117 | 0.02 |
| 10285 | Retinal nerve fibre layer (RNFL) thickness | GCST90014266 | 0.02 |
| 10286 | Total lipids in IDL | GCST90497594 | 0.02 |
| 10287 | LYN/TACC3 ratio | GCST90315350 | 0.02 |
| 10288 | Free cholesterol levels in small HDL | GCST90092948 | 0.02 |
| 10289 | Tyrosine levels | GCST90092993 | 0.02 |
| 10290 | Birth asphyxia | FING00000218 | 0.02 |
| 10291 | CTRC/PLA2G1B ratio | GCST90314310 | 0.02 |
| 10292 | GP6/SEMA4D ratio | GCST90314971 | 0.02 |
| 10293 | Moderate-to-vigorous intensity physical activity during leisure time | GCST90104341 | 0.02 |
| 10294 | MINPP1 levels | GCST90241978 | 0.02 |
| 10295 | SCG2 levels | GCST90470538 | 0.02 |
| 10296 | Whole body fat mass (UKB data field 23100) | GCST90428121 | 0.02 |
| 10297 | IDP dMRI TBSS L2 Superior cerebellar peduncle L | GCST90004136 | 0.02 |
| 10298 | ICD10 O12: Gestational oedema and proteinuria without hypertension | GCST90454231 | 0.02 |
| 10299 | Neutrophill percentage | Blood count | UKBB00000498 | 0.02 |
| 10300 | IDP dMRI ProbtrackX FA ptr l | GCST90003944 | 0.02 |
| 10301 | Feeling guilty | GCST006945 | 0.02 |
| 10302 | SIRPB1 levels | GCST90470640 | 0.02 |
| 10303 | Age at first sexual intercourse | GCST90000045 | 0.02 |
| 10304 | Mild age-related type 2 diabetes | GCST90026416 | 0.02 |
| 10305 | ADH4/CA5A ratio | GCST90313189 | 0.02 |
| 10306 | Biological Mother: High blood pressure | GCST90475490 | 0.02 |
| 10307 | Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers) | FING00000772 | 0.02 |
| 10308 | Free cholesterol to total lipids ratio in small VLDL | GCST90092973 | 0.02 |
| 10309 | CDH17/GALNT3 ratio | GCST90313940 | 0.02 |
| 10310 | GM1 ganglioside (d18:1/16:0) levels | GCST90024724 | 0.02 |
| 10311 | CCN5 levels | GCST90468591 | 0.02 |
| 10312 | ALDH1A1/PKLR ratio | GCST90313245 | 0.02 |
| 10313 | Chronic dermatitis due to solar radiation (PheCode 938.2) | GCST90476288 | 0.02 |
| 10314 | Use of sun/uv protection | Sun exposure | UKBB00000887 | 0.02 |
| 10315 | Financial situation satisfaction | Mental health | UKBB00000249 | 0.02 |
| 10316 | Smoking status (standard GWA) | GCST90267302 | 0.02 |
| 10317 | Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers) | FING00000770 | 0.02 |
| 10318 | DSG3/FABP9 ratio | GCST90314559 | 0.02 |
| 10319 | Linoleic acid levels | GCST90502294 | 0.02 |
| 10320 | Myo-inositol levels | GCST90243527 | 0.02 |
| 10321 | Shortness of breath (PheCode 512.7) | GCST90476040 | 0.02 |
| 10322 | Cataracts | GCST90018594 | 0.02 |
| 10323 | HSIL lesion of the cervix uteri | FING00000624 | 0.02 |
| 10324 | Diseases of oesophagus, stomach and duodenum | FING00000428 | 0.02 |
| 10325 | SF3B4/SIRT2 ratio | GCST90315838 | 0.02 |
| 10326 | Peripheral or central vertigo (PheCode 386.2) | GCST90475907 | 0.02 |
| 10327 | HippSubfield lh volume Whole-hippocampal-head | GCST90002688 | 0.02 |
| 10328 | IL34 levels | GCST90469593 | 0.02 |
| 10329 | ST3GAL1 levels | GCST90470752 | 0.02 |
| 10330 | Raynauds phenomenon disease | GCST90271713 | 0.02 |
| 10331 | High light scatter reticulocyte percentage | Blood count | UKBB00000327 | 0.02 |
| 10332 | Basophil percentage of granulocytes | GCST004634 | 0.02 |
| 10333 | EBAG9/TBCB ratio | GCST90314567 | 0.02 |
| 10334 | AGXT/MME ratio | GCST90313207 | 0.02 |
| 10335 | BACH1/SNAP23 ratio | GCST90313446 | 0.02 |
| 10336 | hematocrit (maximum, inv-norm transformed) | GCST90475338 | 0.02 |
| 10337 | MAP3K5/MAVS ratio | GCST90315379 | 0.02 |
| 10338 | Type 2 diabetes | GCST010118 | 0.02 |
| 10339 | IDP dMRI TBSS L1 Sagittal stratum L | GCST90004106 | 0.02 |
| 10340 | Acquired hypothyroidism (PheCode 244.2) | GCST90475650 | 0.02 |
| 10341 | Omega-3 fatty acids to total fatty acids percentage | GCST90502449 | 0.02 |
| 10342 | Secondary thrombocytopenia (PheCode 287.32) | GCST90475810 | 0.02 |
| 10343 | CLEC6A levels | GCST90468777 | 0.02 |
| 10344 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T424 | ECGU000424 | 0.02 |
| 10345 | Cholesterol | Blood biochemistry | UKBB00000134 | 0.02 |
| 10346 | red cell diameter width (RDW, maximum, inv-norm transformed) | GCST90476357 | 0.02 |
| 10347 | Lager liking | GCST90094789 | 0.02 |
| 10348 | TRIM21 levels | GCST90470964 | 0.02 |
| 10349 | Total bilirubin levels | GCST90278643 | 0.02 |
| 10350 | GRPEL1/MME ratio | GCST90314992 | 0.02 |
| 10351 | rfMRI connectivity (ICA100 edge 619) | GCST90005472 | 0.02 |
| 10352 | Left-hemisphere default mode network to hippocampus white-matter structural connectivity | GCST90302771 | 0.02 |
| 10353 | AFP levels | GCST90278615 | 0.02 |
| 10354 | Dementia | FING00000391 | 0.02 |
| 10355 | Docosahexaenoic acid to total fatty acids percentage | GCST90497270 | 0.02 |
| 10356 | LDL cholesterol levels | GCST90498346 | 0.02 |
| 10357 | CCL5/LAMA4 ratio | GCST90313703 | 0.02 |
| 10358 | FCER2/TCL1A ratio | GCST90314790 | 0.02 |
| 10359 | NRCAM levels | GCST90470082 | 0.02 |
| 10360 | Alanine levels | GCST90497086 | 0.02 |
| 10361 | Urine N1,N12-diacetylspermine levels in chronic kidney disease | GCST90265683 | 0.02 |
| 10362 | SNRPB2 levels | GCST90470697 | 0.02 |
| 10363 | ANPEP/NT5E ratio | GCST90313274 | 0.02 |
| 10364 | Bioavailable testosterone levels | GCST90012103 | 0.02 |
| 10365 | DTI autoptx L2 ifo r tract | GCST90385179 | 0.02 |
| 10366 | Basal cell carcinoma | GCST90013410 | 0.02 |
| 10367 | DTI autoptx L2 ptr l tract | GCST90385185 | 0.02 |
| 10368 | Phospholipids in LDL | GCST90498432 | 0.02 |
| 10369 | BCAM/SEMA7A ratio | GCST90313476 | 0.02 |
| 10370 | Mental and behavioural disorders due to use of tobacco | Mental and behavioural disorders due to psychoactive substance use | UKBB00000460 | 0.02 |
| 10371 | PDGFB/SPINT2 ratio | GCST90315629 | 0.02 |
| 10372 | DPEP1 levels | GCST90090302 | 0.02 |
| 10373 | GALNT10/SEMA7A ratio | GCST90314915 | 0.02 |
| 10374 | All dysplastic lesions of the cervix uteri, vagina or vulva | FING00000061 | 0.02 |
| 10375 | Symptoms concerning nutrition, metabolism, and development (PheCode 1002) | GCST90475556 | 0.02 |
| 10376 | Coffee type: Ground coffee (include espresso, filter etc) (UKB data field 1508_3) | GCST90041803 | 0.02 |
| 10377 | ST8SIA1 levels | GCST90470754 | 0.02 |
| 10378 | CDKN1A/TXLNA ratio | GCST90313979 | 0.02 |
| 10379 | CAMKK1/FOXO1 ratio | GCST90313613 | 0.02 |
| 10380 | T1 CAT volume L LeftAccumbens | GCST90384108 | 0.02 |
| 10381 | F-strong alcohol liking (derived food-liking factor) | GCST90094850 | 0.02 |
| 10382 | Other diseases of urinary system | FING00001013 | 0.02 |
| 10383 | PGA4 levels | GCST90470216 | 0.02 |
| 10384 | Frequency of friend/family visits | Social support | UKBB00000262 | 0.02 |
| 10385 | Phospholipids to Total Lipids in IDL percentage | GCST90497642 | 0.02 |
| 10386 | Frequency of travelling from home to job workplace | Employment | UKBB00000269 | 0.02 |
| 10387 | Vigorous physical activity | GCST006098 | 0.02 |
| 10388 | Urine glycocholenate sulfate* levels in chronic kidney disease | GCST90265292 | 0.02 |
| 10389 | IL1RN/LGALS9 ratio | GCST90315160 | 0.02 |
| 10390 | FGFR4 levels | GCST90469234 | 0.02 |
| 10391 | Cholesteryl esters to total lipids ratio in large LDL | GCST90092859 | 0.02 |
| 10392 | Parkinson's disease or first degree relation to individual with Parkinson's disease | GCST009325 | 0.02 |
| 10393 | Hearing aid user (UKB data field 3393) | GCST90043741 | 0.02 |
| 10394 | KLK11 levels | GCST90012012 | 0.02 |
| 10395 | Mineral and other dietary supplements - Zinc | Medication | UKBB00000476 | 0.02 |
| 10396 | Usual side of head for mobile phone use - Equally left and right | Electronic device use | UKBB00000888 | 0.02 |
| 10397 | Omega-3 fatty acid levels | GCST90502061 | 0.02 |
| 10398 | Migraine with aura | FING00000819 | 0.02 |
| 10399 | Duration of heavy DIY | Physical activity | UKBB00000195 | 0.02 |
| 10400 | IDP dMRI TBSS OD Cerebral peduncle L | GCST90004417 | 0.02 |
| 10401 | DTI autoptx L1 atr l tract | GCST90385141 | 0.02 |
| 10402 | Left-hemisphere control network to left-hemisphere control network white-matter structural connectivity | GCST90302743 | 0.02 |
| 10403 | Glucose | Blood biochemistry | UKBB00000288 | 0.02 |
| 10404 | CDH17/DSG2 ratio | GCST90313939 | 0.02 |
| 10405 | Glomerular filtration rate in non diabetics (creatinine) | GCST003401 | 0.02 |
| 10406 | Polyneuropathy in diabetes (PheCode 250.6) | GCST90475686 | 0.02 |
| 10407 | TP53BP1 levels | GCST90470936 | 0.02 |
| 10408 | Cholesterol levels (UKB data field 30690) | GCST90468066 | 0.02 |
| 10409 | Other soft tissue disorders, not elsewhere classified | FING00001099 | 0.02 |
| 10410 | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | GCST90004345 | 0.02 |
| 10411 | SORT1/ST6GAL1 ratio | GCST90315869 | 0.02 |
| 10412 | Other disorders of glucose regulation and pancreatic internal secretion | FING00001028 | 0.02 |
| 10413 | BA-exvivo rh area BA1 | GCST90003221 | 0.02 |
| 10414 | Irregular menses | FING00000701 | 0.02 |
| 10415 | IDP dMRI ProbtrackX ICVF cst r | GCST90004384 | 0.02 |
| 10416 | GBP6 levels | GCST90241368 | 0.02 |
| 10417 | CA5A/GSTA1 ratio | GCST90313591 | 0.02 |
| 10418 | Transient global amnesia | FING00001374 | 0.02 |
| 10419 | Total lipids in small HDL (UKB data field 23573) | GCST90269670 | 0.02 |
| 10420 | Cream liking | GCST90094746 | 0.02 |
| 10421 | ANXA3/ENO2 ratio | GCST90313281 | 0.02 |
| 10422 | aseg lh volume VentralDC | GCST90002627 | 0.02 |
| 10423 | Restless legs syndrome (PheCode 327.71) | GCST90475829 | 0.02 |
| 10424 | RCC1 levels | GCST90470443 | 0.02 |
| 10425 | Omega-3 fatty acids to total fatty acids percentage | GCST90502081 | 0.02 |
| 10426 | Tyrosine levels | GCST90500143 | 0.02 |
| 10427 | Asthma | respiratory | UKBB00000054 | 0.02 |
| 10428 | Hair colour (natural, before greying): Black (UKB data field 1747_5) | GCST90041840 | 0.02 |
| 10429 | BST2/CEACAM1 ratio | GCST90313537 | 0.02 |
| 10430 | Cereal bar liking | GCST90094728 | 0.02 |
| 10431 | BCR/GOPC ratio | GCST90313491 | 0.02 |
| 10432 | Cholesteryl Esters to Total Lipids in Very Small VLDL percentage | GCST90500754 | 0.02 |
| 10433 | ZBTB17 levels | GCST90471096 | 0.02 |
| 10434 | Platelet count during third trimester of pregnancy | GCST90302226 | 0.02 |
| 10435 | CLTA levels | GCST90468791 | 0.02 |
| 10436 | CEACAM8/PGLYRP1 ratio | GCST90314003 | 0.02 |
| 10437 | Lysophosphatidylcholine (20:3) [sn1] levels | GCST90024169 | 0.02 |
| 10438 | SLAMF7/TXNDC15 ratio | GCST90315850 | 0.02 |
| 10439 | Neoplasm of uncertain behavior of skin (PheCode 173) | GCST90475585 | 0.02 |
| 10440 | BLVRB/CA3 ratio | GCST90313523 | 0.02 |
| 10441 | Actinic keratosis (PheCode 702.1) | GCST90476204 | 0.02 |
| 10442 | SLC5A8 levels | GCST90242850 | 0.02 |
| 10443 | CSTB levels | GCST90468898 | 0.02 |
| 10444 | IDP dMRI ProbtrackX OD ilf r | GCST90004465 | 0.02 |
| 10445 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 12) | GCST90320831 | 0.02 |
| 10446 | Use of disulfiram, acamprosate or naltrexone | FING00001410 | 0.02 |
| 10447 | Principal component-derived dietary pattern 4 | GCST90133009 | 0.02 |
| 10448 | Facial skin colour (CIELAB index b* value) | GCST90020056 | 0.02 |
| 10449 | Clinical LDL cholesterol levels | GCST90497219 | 0.02 |
| 10450 | CD80 on monocyte | GCST90002039 | 0.02 |
| 10451 | LPCAT2/SERPINB8 ratio | GCST90315328 | 0.02 |
| 10452 | SERPINA11 levels | GCST90470580 | 0.02 |
| 10453 | Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093043 | 0.02 |
| 10454 | CEACAM20 levels | GCST90468693 | 0.02 |
| 10455 | Left-hemisphere dorsal attention network to amygdala white-matter structural connectivity | GCST90302706 | 0.02 |
| 10456 | Primary angle-closure glaucoma | FING00001210 | 0.02 |
| 10457 | Secondary hypothyroidism (PheCode 244.1) | GCST90475649 | 0.02 |
| 10458 | Right-hemisphere somatomotor network to amygdala white-matter structural connectivity | GCST90302799 | 0.02 |
| 10459 | F-fatty food liking (derived food-liking factor) | GCST90094761 | 0.02 |
| 10460 | CPA1/CPB1 ratio | GCST90314202 | 0.02 |
| 10461 | BAG6/USP8 ratio | GCST90313451 | 0.02 |
| 10462 | Cholelithiasis | Disorders of gallbladder, biliary tract and pancreas | UKBB00000132 | 0.02 |
| 10463 | EPO levels | GCST90469136 | 0.02 |
| 10464 | Microalbumin in urine | Urine assays | UKBB00000467 | 0.02 |
| 10465 | Triglycerides to total lipids ratio in small VLDL | GCST90092979 | 0.02 |
| 10466 | Symptoms involving digestive system (PheCode 561) | GCST90476069 | 0.02 |
| 10467 | HippSubfield rh volume CA4-body | GCST90002705 | 0.02 |
| 10468 | Total Lipids in LDL | GCST90498396 | 0.02 |
| 10469 | Juvenile rheumatoid arthirtis | FING00000706 | 0.02 |
| 10470 | Qualifications - None of the above | Education | UKBB00000729 | 0.02 |
| 10471 | Completion of the aide-memoire | GCST90012793 | 0.02 |
| 10472 | IDP dMRI TBSS L1 Body of corpus callosum | GCST90004078 | 0.02 |
| 10473 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T458 | ECGU000458 | 0.02 |
| 10474 | Crohn disease (strict definition, require KELA, min 2 HDR) | FING00000366 | 0.02 |
| 10475 | AmygNuclei rh volume Basal-nucleus | GCST90002659 | 0.02 |
| 10476 | aparc-DKTatlas rh volume superiorparietal | GCST90002920 | 0.02 |
| 10477 | Mother's age | Family history | UKBB00000484 | 0.02 |
| 10478 | Statin-associated type 2 diabetes mellitus | GCST90652517 | 0.02 |
| 10479 | IDP dMRI TBSS L1 Cerebral peduncle L | GCST90004090 | 0.02 |
| 10480 | Dorsalgia | FING00000472 | 0.02 |
| 10481 | NT5C levels | GCST90470092 | 0.02 |
| 10482 | Sum eosinophil basophil counts | GCST004624 | 0.02 |
| 10483 | aparc-Desikan rh volume superiorparietal | GCST90002829 | 0.02 |
| 10484 | KLK8 levels | GCST90469707 | 0.02 |
| 10485 | Tobacco use | FING00001365 | 0.02 |
| 10486 | Other mental disorder | mental disorders | UKBB00000614 | 0.02 |
| 10487 | INPP1/TBCC ratio | GCST90315180 | 0.02 |
| 10488 | CLPS/PRSS2 ratio | GCST90314141 | 0.02 |
| 10489 | Been in a confiding relationship as an adult | Traumatic events | UKBB00000088 | 0.02 |
| 10490 | 1-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levels | GCST90200046 | 0.02 |
| 10491 | EDAR levels | GCST90469068 | 0.02 |
| 10492 | REST UKBBICA NODEamps25 0007 | GCST90385490 | 0.02 |
| 10493 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T280 | ECGU000280 | 0.02 |
| 10494 | PVALB levels | GCST90470393 | 0.02 |
| 10495 | Diabetes (weighted GWA) | GCST90267279 | 0.02 |
| 10496 | SERPINB6/TXNDC5 ratio | GCST90315832 | 0.02 |
| 10497 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T279 | ECGA000279 | 0.02 |
| 10498 | IGSF8/VSIR ratio | GCST90315141 | 0.02 |
| 10499 | Concentration of large LDL particles | GCST90498037 | 0.02 |
| 10500 | Mineral and other dietary supplements - None of the above | Medication | UKBB00000474 | 0.02 |
| 10501 | Other disorders of ear | FING00001023 | 0.02 |
| 10502 | Phosphatidylinositol (20:0_20:4) levels | GCST90025083 | 0.02 |
| 10503 | Cardiorespiratory fitness (vo2 max) | GCST90093317 | 0.02 |
| 10504 | Principal component-derived dietary pattern 30 | GCST90133035 | 0.02 |
| 10505 | RRM2B levels | GCST90470500 | 0.02 |
| 10506 | Sleep related movement disorders (PheCode 327.7) | GCST90475827 | 0.02 |
| 10507 | Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levels | GCST90200105 | 0.02 |
| 10508 | Non-cancer illness code, self-reported - gout | Medical conditions | UKBB00000512 | 0.02 |
| 10509 | Principal component-derived dietary pattern 9 | GCST90133014 | 0.02 |
| 10510 | Mean platelet volume | GCST90002395 | 0.02 |
| 10511 | CALCOCO1/TJAP1 ratio | GCST90313611 | 0.02 |
| 10512 | ICD10 C61: Malignant neoplasm of prostate | GCST90043894 | 0.02 |
| 10513 | UBAC1 levels | GCST90470999 | 0.02 |
| 10514 | SORT1 levels | GCST90470710 | 0.02 |
| 10515 | MAN2B2 levels | GCST90469844 | 0.02 |
| 10516 | CCL20 levels | GCST90012077 | 0.02 |
| 10517 | LMOD1 levels | GCST90469783 | 0.02 |
| 10518 | Mood [affective] disorders | FING00000836 | 0.02 |
| 10519 | T1 CAT volume R RightThalamus | GCST90384097 | 0.02 |
| 10520 | F-dairy liking (derived food-liking factor) | GCST90094751 | 0.02 |
| 10521 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T457 | ECGA000457 | 0.02 |
| 10522 | Atopic dermatitis | FING00000125 | 0.02 |
| 10523 | OLFM4 levels | GCST90470121 | 0.02 |
| 10524 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 70) | GCST90320889 | 0.02 |
| 10525 | Polyunsaturated fatty acid levels | GCST90502618 | 0.02 |
| 10526 | CD22/FCER2 ratio | GCST90313756 | 0.02 |
| 10527 | Juvenile arthritis (FINNGEN) | FING00000704 | 0.02 |
| 10528 | APOB levels | GCST90497137 | 0.02 |
| 10529 | Sleep disorders (combined) | FING00001311 | 0.02 |
| 10530 | MMP1/MMP3 ratio | GCST90315461 | 0.02 |
| 10531 | HPCAL1/NUDC ratio | GCST90315074 | 0.02 |
| 10532 | Restless legs syndrome | GCST90435387 | 0.02 |
| 10533 | HippSubfield rh volume Whole-hippocampus | GCST90002711 | 0.02 |
| 10534 | IPCEF1/SERPINE1 ratio | GCST90315184 | 0.02 |
| 10535 | Other/unspecified dorsalgia | FING00001124 | 0.02 |
| 10536 | PRSS2 levels | GCST90470343 | 0.02 |
| 10537 | Alcohol consumption | GCST90133003 | 0.02 |
| 10538 | Croissant liking | GCST90094748 | 0.02 |
| 10539 | AGXT/GRPEL1 ratio | GCST90313205 | 0.02 |
| 10540 | Mean diameter of VLDL particles | GCST90132734 | 0.02 |
| 10541 | Psoas tendinitis | FING00001221 | 0.02 |
| 10542 | Lymphocyte percentage | Blood count | UKBB00000412 | 0.02 |
| 10543 | Plasma ascorbic acid 2-sulfate levels in chronic kidney disease | GCST90264832 | 0.02 |
| 10544 | Cervicobrachial syndrome | FING00000266 | 0.02 |
| 10545 | SLC4A1 levels | GCST90470663 | 0.02 |
| 10546 | CPB1/PRSS2 ratio | GCST90314211 | 0.02 |
| 10547 | Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5) | GCST90132973 | 0.02 |
| 10548 | Cerebrospinal fluid S-1-pyrroline-5-carboxylate levels | GCST90318235 | 0.02 |
| 10549 | USP8/WASF1 ratio | GCST90315944 | 0.02 |
| 10550 | Attention deficit hyperactivity disorder (ADuLT model adjusted for sex) | GCST90275136 | 0.02 |
| 10551 | aseg lh intensity Pallidum | GCST90003771 | 0.02 |
| 10552 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90025743 | 0.02 |
| 10553 | Acceptance of an invitation to participate in a mental health questionnaire | GCST90012792 | 0.02 |
| 10554 | GZMH levels | GCST90469425 | 0.02 |
| 10555 | Nummular dermatitis | FING00000893 | 0.02 |
| 10556 | RNASE3 levels | GCST90470477 | 0.02 |
| 10557 | Attention deficit hyperactivity disorder (adjusted for age, sex) | GCST90275147 | 0.02 |
| 10558 | SEZ6L levels | GCST90470607 | 0.02 |
| 10559 | Feeling hurt | GCST006951 | 0.02 |
| 10560 | BMP7 levels | GCST90088157 | 0.02 |
| 10561 | Diabetes mellitus (UKB data field 2443) | GCST90043627 | 0.02 |
| 10562 | KLF4 levels | GCST90469694 | 0.02 |
| 10563 | Mean corpuscular hemoglobin concentration | GCST90018745 | 0.02 |
| 10564 | KL levels | GCST90091246 | 0.02 |
| 10565 | Omega-6 fatty acid levels | GCST90502101 | 0.02 |
| 10566 | IRAK1/SPRY2 ratio | GCST90315196 | 0.02 |
| 10567 | Hemoglobin concentration | GCST004615 | 0.02 |
| 10568 | GLB1/GUSB ratio | GCST90314931 | 0.02 |
| 10569 | ANXA4/HSPB1 ratio | GCST90313292 | 0.02 |
| 10570 | ICAM2/IL7R ratio | GCST90315117 | 0.02 |
| 10571 | IDP dMRI TBSS L3 Superior cerebellar peduncle L | GCST90004184 | 0.02 |
| 10572 | DECR1/MAP2K6 ratio | GCST90314447 | 0.02 |
| 10573 | ANXA3/BID ratio | GCST90313279 | 0.02 |
| 10574 | IDP T1 FIRST right pallidum volume | GCST90002443 | 0.02 |
| 10575 | CLEC1B/EGF ratio | GCST90314089 | 0.02 |
| 10576 | Phospholipid levels in very large HDL | GCST90132642 | 0.02 |
| 10577 | Number of non-cancer illnesses (standard GWA) | GCST90267290 | 0.02 |
| 10578 | SPARCL1 levels | GCST90242870 | 0.02 |
| 10579 | Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI) | GCST003658 | 0.02 |
| 10580 | GAS6/NOTCH1 ratio | GCST90314918 | 0.02 |
| 10581 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T459 | ECGU000459 | 0.02 |
| 10582 | AHSP levels | GCST90468264 | 0.02 |
| 10583 | CRACR2A/LBR ratio | GCST90314228 | 0.02 |
| 10584 | INPP5J levels | GCST90469618 | 0.02 |
| 10585 | CSF1/IFNGR1 ratio | GCST90314283 | 0.02 |
| 10586 | Omega-6 fatty acid levels | GCST90502502 | 0.02 |
| 10587 | Fluid intelligence score (baseline) | GCST90565842 | 0.02 |
| 10588 | F9/FETUB ratio | GCST90314746 | 0.02 |
| 10589 | NINJ1 levels | GCST90470049 | 0.02 |
| 10590 | Hair colour (natural, before greying) - Dark brown | Sun exposure | UKBB00000297 | 0.02 |
| 10591 | aseg lh volume Accumbens-area | GCST90002626 | 0.02 |
| 10592 | Cysteine-glutathione disulfide levels | GCST90199784 | 0.02 |
| 10593 | Principal component-derived dietary pattern 20 | GCST90133025 | 0.02 |
| 10594 | Hematocrit | GCST004604 | 0.02 |
| 10595 | Types of physical activity in last 4 weeks - Walking for pleasure (not as a means of transport) | Physical activity | UKBB00000875 | 0.02 |
| 10596 | C20:4 Lysophosphatidylcholine levels in chronic kidney disease | GCST90257570 | 0.02 |
| 10597 | Light-intensity physical activity duration | GCST90061421 | 0.02 |
| 10598 | CXCL5/SPARC ratio | GCST90314355 | 0.02 |
| 10599 | FADD/PTPN6 ratio | GCST90314775 | 0.02 |
| 10600 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T455 | ECGA000455 | 0.02 |
| 10601 | white blood cell count (WBC, maximum, inv-norm transformed) | GCST90476451 | 0.02 |
| 10602 | AXIN1/CDKN1A ratio | GCST90313403 | 0.02 |
| 10603 | Volume of right basal nucleus | GCST90475015 | 0.02 |
| 10604 | GKN1 levels | GCST90469353 | 0.02 |
| 10605 | Cough (PheCode 512.8) | GCST90476041 | 0.02 |
| 10606 | wg rh intensity-contrast lingual | GCST90003839 | 0.02 |
| 10607 | Urine proline levels in chronic kidney disease | GCST90265873 | 0.02 |
| 10608 | Smoking status (weighted GWA) | GCST90267303 | 0.02 |
| 10609 | DTI TBSS L1 Anterior corona radiata L | GCST90384451 | 0.02 |
| 10610 | Codeine or tramadol medication | FING00000311 | 0.02 |
| 10611 | Cholesterol to total lipids ratio in small VLDL | GCST90092969 | 0.02 |
| 10612 | Phospholipids to Total Lipids in Large LDL percentage | GCST90498071 | 0.02 |
| 10613 | Adenomyosis (Endometriosis of uterus) | FING00000042 | 0.02 |
| 10614 | KITLG levels | GCST90274833 | 0.02 |
| 10615 | Number of treatments/medications taken | Medications | UKBB00000542 | 0.02 |
| 10616 | Blood urea nitrogen levels | GCST90278623 | 0.02 |
| 10617 | Inflammatory bowel disease, strict (require KELA) | FING00000675 | 0.02 |
| 10618 | PCDH1/TNFRSF11A ratio | GCST90315608 | 0.02 |
| 10619 | Acute sinusitis | FING00000031 | 0.02 |
| 10620 | BIN2/EREG ratio | GCST90313503 | 0.02 |
| 10621 | Plasma N,N,N-trimethyl-5-aminovalerate levels in chronic kidney disease | GCST90265671 | 0.02 |
| 10622 | Estimated glomerular filtration rate (creatinine) | GCST90103634 | 0.02 |
| 10623 | CDKN1A/ENO2 ratio | GCST90313969 | 0.02 |
| 10624 | Linoleic acid levels | GCST90502010 | 0.02 |
| 10625 | rfMRI connectivity (ICA100 edge 387) | GCST90005240 | 0.02 |
| 10626 | Intelligence | GCST006250 | 0.02 |
| 10627 | Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500716 | 0.02 |
| 10628 | Phospholipids to total lipids ratio in medium LDL | GCST90092913 | 0.02 |
| 10629 | Recent feelings of tiredness or low energy | Depression | UKBB00000740 | 0.02 |
| 10630 | Seen doctor (GP) for nerves, anxiety, tension or depression | Mental health | UKBB00000765 | 0.02 |
| 10631 | Acute pancreatitis | GCST90255375 | 0.02 |
| 10632 | Sphingomyelin (d18:1/20:0, d16:1/22:0) levels | GCST90200001 | 0.02 |
| 10633 | VWC2L levels | GCST90471063 | 0.02 |
| 10634 | CELA2A levels | GCST90468701 | 0.02 |
| 10635 | CABP2 levels | GCST90468519 | 0.02 |
| 10636 | IDP dMRI ProbtrackX L1 cgc r | GCST90004251 | 0.02 |
| 10637 | CEACAM21 levels | GCST90468694 | 0.02 |
| 10638 | Noninfective enteritis and colitis | FING00000881 | 0.02 |
| 10639 | NFATC3 levels | GCST90470034 | 0.02 |
| 10640 | PEAR1/SCARF1 ratio | GCST90315642 | 0.02 |
| 10641 | PHLDB1 levels | GCST90470225 | 0.02 |
| 10642 | Salami liking | GCST90094825 | 0.02 |
| 10643 | aseg rh intensity Pallidum | GCST90003785 | 0.02 |
| 10644 | Medication for pain relief, constipation, heartburn - Laxatives (e.g. Dulcolax, Senokot) | Medication | UKBB00000456 | 0.02 |
| 10645 | Porridge liking | GCST90094815 | 0.02 |
| 10646 | Lung cancer | GCST90018655 | 0.02 |
| 10647 | neutrophil (absolute count, maximum, inv-norm transformed) | GCST90475526 | 0.02 |
| 10648 | ESAM/THPO ratio | GCST90314719 | 0.02 |
| 10649 | Current employment status - In paid employment or self-employed | Employment | UKBB00000158 | 0.02 |
| 10650 | aseg rh volume Accumbens-area | GCST90002643 | 0.02 |
| 10651 | Fasting glucose | GCST90002232 | 0.02 |
| 10652 | RGMB/TNFRSF21 ratio | GCST90315772 | 0.02 |
| 10653 | Neuroticism | GCST002920 | 0.02 |
| 10654 | Chronic myeloproliferative disease | FING00000294 | 0.02 |
| 10655 | HippSubfield lh volume Whole-hippocampus | GCST90002689 | 0.02 |
| 10656 | DTI TBSS MD Fornix cres+Stria terminalis R | GCST90384610 | 0.02 |
| 10657 | AHSP/BLVRB ratio | GCST90313214 | 0.02 |
| 10658 | BBQ/grilled meat liking | GCST90094698 | 0.02 |
| 10659 | Phosphatidylethanolamine_40:6_[M-H]1- levels | GCST90060365 | 0.02 |
| 10660 | Omega-6 fatty acid levels | GCST90502103 | 0.02 |
| 10661 | Chronic sinusitis (PheCode 475) | GCST90476020 | 0.02 |
| 10662 | Depression (broad) | GCST005902 | 0.02 |
| 10663 | KLK4 levels | GCST90469704 | 0.02 |
| 10664 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T472 | ECGA000472 | 0.02 |
| 10665 | CD200R1/CLEC4G ratio | GCST90313748 | 0.02 |
| 10666 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90499340 | 0.02 |
| 10667 | MAP4K5/TBCB ratio | GCST90315384 | 0.02 |
| 10668 | IDP T1 FAST ROIs R cerebellum crus I | GCST90002571 | 0.02 |
| 10669 | Red blood cell erythrocyte distribution width (UKB data field 30070) | GCST90468099 | 0.02 |
| 10670 | CD163/SIGLEC1 ratio | GCST90313739 | 0.02 |
| 10671 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3) | GCST90320822 | 0.02 |
| 10672 | Daytime dozing / sleeping (narcolepsy) | Sleep | UKBB00000164 | 0.02 |
| 10673 | Etiocholanolone glucuronide levels | GCST90199964 | 0.02 |
| 10674 | Concentration of IDL particles | GCST90497606 | 0.02 |
| 10675 | Asthma | GCST010042 | 0.02 |
| 10676 | Chromatiales abundance in stool | GCST90032318 | 0.02 |
| 10677 | CPA1/PRSS2 ratio | GCST90314206 | 0.02 |
| 10678 | GPRC5C levels | GCST90469398 | 0.02 |
| 10679 | Cholesteryl esters to total lipids ratio in medium VLDL | GCST90092919 | 0.02 |
| 10680 | Bacterial pneumoniae | FING00000139 | 0.02 |
| 10681 | Principal component-derived dietary pattern 44 | GCST90133049 | 0.02 |
| 10682 | Crohns disease | GCST90468121 | 0.02 |
| 10683 | Age at first sexual intercourse | GCST90000046 | 0.02 |
| 10684 | FLT1 levels | GCST90469249 | 0.02 |
| 10685 | Lymphocyte count | GCST90002316 | 0.02 |
| 10686 | Types of transport used (excluding work) - Cycle | Physical activity | UKBB00000877 | 0.02 |
| 10687 | ZNRD2 levels | GCST90471103 | 0.02 |
| 10688 | CPB1/REG1A ratio | GCST90314212 | 0.02 |
| 10689 | SPINK1 levels | GCST90470721 | 0.02 |
| 10690 | CD160 levels | GCST90468599 | 0.02 |
| 10691 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60) | GCST90320879 | 0.02 |
| 10692 | T1 CAT volume L VIIIb | GCST90384130 | 0.02 |
| 10693 | Total cholesterol levels | GCST90500015 | 0.02 |
| 10694 | Personal history of certain other diseases | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000642 | 0.02 |
| 10695 | MNDA levels | GCST90469927 | 0.02 |
| 10696 | BSG/TNFRSF4 ratio | GCST90313536 | 0.02 |
| 10697 | Rheumatoid arthritis | FING00001267 | 0.02 |
| 10698 | HippSubfield lh volume CA4-head | GCST90002682 | 0.02 |
| 10699 | Degenerative skin conditions and other dermatoses (PheCode 702) | GCST90476202 | 0.02 |
| 10700 | SPOCK1 levels | GCST90470730 | 0.02 |
| 10701 | HippSubfield rh volume hippocampal-fissure | GCST90002694 | 0.02 |
| 10702 | Bifidobacterium catenulatum abundance in stool | GCST90032224 | 0.02 |
| 10703 | Skin and soft tissue infections | GCST90013411 | 0.02 |
| 10704 | MST1 levels | GCST90469952 | 0.02 |
| 10705 | IL18BP/ROR1 ratio | GCST90315155 | 0.02 |
| 10706 | Lymphocyte percentage (UKB data field 30180) | GCST90468083 | 0.02 |
| 10707 | 1-ribosyl-imidazoleacetate levels | GCST90199815 | 0.02 |
| 10708 | Uterine fibroids | GCST90461958 | 0.02 |
| 10709 | Creatinine levels | GCST90132719 | 0.02 |
| 10710 | Mineral and other dietary supplements - Glucosamine | Medication | UKBB00000473 | 0.02 |
| 10711 | Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) | GCST90475097 | 0.02 |
| 10712 | Methods of admission to hospital (recoded) - Emergency admission: A&E | Summary Administration | UKBB00000464 | 0.02 |
| 10713 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475462 | 0.02 |
| 10714 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T460 | ECGU000460 | 0.02 |
| 10715 | CLPS/PLA2G1B ratio | GCST90314140 | 0.02 |
| 10716 | Cholecystectomy | FING00000273 | 0.02 |
| 10717 | Ever smoked | Smoking | UKBB00000221 | 0.02 |
| 10718 | aparc-DKTatlas lh area precentral | GCST90003256 | 0.02 |
| 10719 | Degeneration of intervertebral disc (PheCode 722.6) | GCST90476238 | 0.02 |
| 10720 | MAX/STK24 ratio | GCST90315404 | 0.02 |
| 10721 | Nontoxic goitre/thyroid nodule | FING00000887 | 0.02 |
| 10722 | Abdominal pain | symptoms | UKBB00000003 | 0.02 |
| 10723 | Omega-6 fatty acid levels | GCST90502514 | 0.02 |
| 10724 | ThalamNuclei rh volume Pf | GCST90002746 | 0.02 |
| 10725 | Sarcoidosis | GCST90503483 | 0.02 |
| 10726 | CD86 levels | GCST90468654 | 0.02 |
| 10727 | ARHGEF12/IRAK4 ratio | GCST90313350 | 0.02 |
| 10728 | Leisure/social activities - Adult education class | Social support | UKBB00000398 | 0.02 |
| 10729 | Medication use (HMG CoA reductase inhibitors) | GCST90018769 | 0.02 |
| 10730 | Appendectomy | FING00000104 | 0.02 |
| 10731 | HBEGF/PLXNA4 ratio | GCST90315036 | 0.02 |
| 10732 | CRACR2A/DNMBP ratio | GCST90314226 | 0.02 |
| 10733 | Personality disorders (more control exclusions) | FING00001163 | 0.02 |
| 10734 | CPA1/CTRC ratio | GCST90314204 | 0.02 |
| 10735 | Bicarbonate (mean, inv-norm transformed) | GCST90475148 | 0.02 |
| 10736 | Creatinine levels | GCST90092815 | 0.02 |
| 10737 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditions | UKBB00000098 | 0.02 |
| 10738 | Total cholesterol minus HDL-C levels | GCST90092930 | 0.02 |
| 10739 | Glomerular filtration rate (creatinine) | GCST003372 | 0.02 |
| 10740 | KIR2DL2 levels | GCST90469684 | 0.02 |
| 10741 | Thyroid cancer (PheCode 193) | GCST90475600 | 0.02 |
| 10742 | Neutrophil percentage of white cells | GCST90002399 | 0.02 |
| 10743 | SCARF1/SUSD1 ratio | GCST90315811 | 0.02 |
| 10744 | Open bite | FING00000903 | 0.02 |
| 10745 | Coffee type - Decaffeinated coffee (any type) | Diet | UKBB00000139 | 0.02 |
| 10746 | Non-cancer illness code, self-reported - asthma | Medical conditions | UKBB00000506 | 0.02 |
| 10747 | Current Smoker | FING00000371 | 0.02 |
| 10748 | Cholesterol to Total Lipids in Large LDL percentage | GCST90497938 | 0.02 |
| 10749 | ATP5IF1/FXN ratio | GCST90313386 | 0.02 |
| 10750 | IL15/NCR1 ratio | GCST90315150 | 0.02 |
| 10751 | Type 2 diabetes | GCST90086072 | 0.02 |
| 10752 | Right ventricular stroke volume | GCST90268122 | 0.02 |
| 10753 | Pain in limb (PheCode 773) | GCST90476270 | 0.02 |
| 10754 | PNLIP levels | GCST90470275 | 0.02 |
| 10755 | Sleep apnoea | FING00001309 | 0.02 |
| 10756 | Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activity | UKBB00000873 | 0.02 |
| 10757 | Do you smoke now? | GCST90476389 | 0.02 |
| 10758 | Roast chicken liking | GCST90094821 | 0.02 |
| 10759 | Raw carrot liking | GCST90094818 | 0.02 |
| 10760 | TNFAIP8 levels | GCST90470898 | 0.02 |
| 10761 | ThalamNuclei rh volume MGN | GCST90002737 | 0.02 |
| 10762 | CD27/NECTIN4 ratio | GCST90313775 | 0.02 |
| 10763 | REG1A/TFF3 ratio | GCST90315764 | 0.01 |
| 10764 | CALCOCO1/IKBKG ratio | GCST90313602 | 0.01 |
| 10765 | STAMBP/WWP2 ratio | GCST90315888 | 0.01 |
| 10766 | Sleep apnoea, including avohilmo | FING00001310 | 0.01 |
| 10767 | APOL1 levels | GCST90468341 | 0.01 |
| 10768 | ARSA levels | GCST90468368 | 0.01 |
| 10769 | Physical activity (confirmatory factor analysis Factor 23) | GCST90309357 | 0.01 |
| 10770 | AXIN1/ITGB1BP2 ratio | GCST90313412 | 0.01 |
| 10771 | Polymyalgia rheumatica | FING00001188 | 0.01 |
| 10772 | Multiple sclerosis | GCST90475833 | 0.01 |
| 10773 | Alanine levels (UKB data field 23460) | GCST90269557 | 0.01 |
| 10774 | Bread intake | Diet | UKBB00000105 | 0.01 |
| 10775 | EPS8L2/LGALS4 ratio | GCST90314685 | 0.01 |
| 10776 | Pulmonary embolism and infarction, acute (PheCode 415.11) | GCST90475946 | 0.01 |
| 10777 | Strenuous sports or other exercises | GCST006100 | 0.01 |
| 10778 | Low back pain | FING00000730 | 0.01 |
| 10779 | DTI TBSS MD Body of corpus callosum | GCST90384575 | 0.01 |
| 10780 | A1BG levels | GCST90468185 | 0.01 |
| 10781 | Linoleic acid levels | GCST90502306 | 0.01 |
| 10782 | Ulcerative colitis | GCST90446795 | 0.01 |
| 10783 | Neutrophill percentage (UKB data field 30200) | GCST90468093 | 0.01 |
| 10784 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T245 | ECGU000245 | 0.01 |
| 10785 | Alcohol dependence | FING00000050 | 0.01 |
| 10786 | Curry liking | GCST90094750 | 0.01 |
| 10787 | Medication use (drugs affecting bone structure and mineralization) | GCST90018773 | 0.01 |
| 10788 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502397 | 0.01 |
| 10789 | X-13435 levels | GCST90243811 | 0.01 |
| 10790 | Non-allergic asthma (mode) (more control exclusions) | FING00000869 | 0.01 |
| 10791 | Milky sweets liking | GCST90094802 | 0.01 |
| 10792 | ISEI occupational score | GCST90446160 | 0.01 |
| 10793 | FOXO1/NUB1 ratio | GCST90314874 | 0.01 |
| 10794 | Atrophic disorders of skin | FING00000129 | 0.01 |
| 10795 | FCRL1/TNFRSF13C ratio | GCST90314796 | 0.01 |
| 10796 | Hair colour (natural, before greying): Red (UKB data field 1747_2) | GCST90041837 | 0.01 |
| 10797 | Type 1 diabetes | GCST90432066 | 0.01 |
| 10798 | VSIG10 levels | GCST90471050 | 0.01 |
| 10799 | AZU1/CEACAM8 ratio | GCST90313424 | 0.01 |
| 10800 | Neoplasm of uncertain behavior (PheCode 199) | GCST90475606 | 0.01 |
| 10801 | SMAD1/ZBTB16 ratio | GCST90315853 | 0.01 |
| 10802 | Polyarthropathies | FING00001180 | 0.01 |
| 10803 | DLL1/TGFBR2 ratio | GCST90314499 | 0.01 |
| 10804 | BTN2A1/CSF1 ratio | GCST90313541 | 0.01 |
| 10805 | Total cholesterol minus HDL-C levels | GCST90499129 | 0.01 |
| 10806 | Other and unspecified urticaria | FING00000957 | 0.01 |
| 10807 | rfMRI connectivity (ICA25 edge 103) | GCST90004746 | 0.01 |
| 10808 | LCN2 levels | GCST90469747 | 0.01 |
| 10809 | Dermatophytosis of nail (PheCode 110.11) | GCST90475562 | 0.01 |
| 10810 | Malignant neoplasm, excluding all cancers (controls excluding all cancers) | FING00000780 | 0.01 |
| 10811 | Biological Father: Cancer, Skin | GCST90475240 | 0.01 |
| 10812 | Cholelithiasis | FING00000275 | 0.01 |
| 10813 | Medication use (adrenergics, inhalants) | GCST90018779 | 0.01 |
| 10814 | CCL17/PDGFB ratio | GCST90313688 | 0.01 |
| 10815 | Melanomas of skin, dx or hx (PheCode 172.1) | GCST90475577 | 0.01 |
| 10816 | CNDP1/EGFR ratio | GCST90314146 | 0.01 |
| 10817 | TGFBR2/TNFRSF1A ratio | GCST90315918 | 0.01 |
| 10818 | Malignant melanoma | GCST90468141 | 0.01 |
| 10819 | Linoleic acid to total fatty acids percentage | GCST90502025 | 0.01 |
| 10820 | Lymphocyte percentage of white cells | GCST90002389 | 0.01 |
| 10821 | SDC4 levels | GCST90470559 | 0.01 |
| 10822 | Linoleic acid levels | GCST90092880 | 0.01 |
| 10823 | Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9) | GCST90475908 | 0.01 |
| 10824 | All anxiety disorders | FING00000059 | 0.01 |
| 10825 | Age at first sexual intercourse | GCST90000047 | 0.01 |
| 10826 | Total lipid levels in lipoprotein particles | GCST90500085 | 0.01 |
| 10827 | GSTA3/KRT18 ratio | GCST90314997 | 0.01 |
| 10828 | Educational attainment | GCST002598 | 0.01 |
| 10829 | FCRL5/MZB1 ratio | GCST90314804 | 0.01 |
| 10830 | Postinflammatory pulmonary fibrosis (PheCode 502) | GCST90476032 | 0.01 |
| 10831 | Paraproteinemia (PheCode 270.32) | GCST90475710 | 0.01 |
| 10832 | CD74/TNFRSF21 ratio | GCST90313897 | 0.01 |
| 10833 | Alkylphosphatidylcholine (O-32:1) levels | GCST90024923 | 0.01 |
| 10834 | B4GALT1/B4GAT1 ratio | GCST90313429 | 0.01 |
| 10835 | Lower back pain or/and sciatica | FING00000731 | 0.01 |
| 10836 | Stearate 18:0 levels | GCST90243431 | 0.01 |
| 10837 | Cholesteryl ester_18:2_[M+NH4]1+ levels | GCST90060220 | 0.01 |
| 10838 | Mouth/teeth dental problems - Loose teeth | Mouth | UKBB00000487 | 0.01 |
| 10839 | SH2D1A levels | GCST90470617 | 0.01 |
| 10840 | Tinnitus | GCST90448242 | 0.01 |
| 10841 | CD79B/CKAP4 ratio | GCST90313898 | 0.01 |
| 10842 | eGFR in diabetes mellitus (loose) (minimal adjustment) | GCST90624783 | 0.01 |
| 10843 | Lifetime number of sexual partners | Sexual factors | UKBB00000406 | 0.01 |
| 10844 | KLK15 levels | GCST90469701 | 0.01 |
| 10845 | CCL18 levels | GCST90468570 | 0.01 |
| 10846 | ART3 levels | GCST90468370 | 0.01 |
| 10847 | X-12707 levels | GCST90200502 | 0.01 |
| 10848 | Loneliness, isolation | Mental health | UKBB00000408 | 0.01 |
| 10849 | Cholesteryl Esters to Total Lipids in Large LDL percentage | GCST90497967 | 0.01 |
| 10850 | Calcific tendinitis of shoulder | FING00000235 | 0.01 |
| 10851 | ADAMTS15/SULT2A1 ratio | GCST90313171 | 0.01 |
| 10852 | Ovarian cyst | FING00001132 | 0.01 |
| 10853 | Lichen simplex chronicus and prurigo | FING00000725 | 0.01 |
| 10854 | HLA-DMA levels | GCST90241448 | 0.01 |
| 10855 | lymphocyte (absolute count, mean, inv-norm transformed) | GCST90475426 | 0.01 |
| 10856 | T1 CAT volume L LeftPutamen | GCST90384100 | 0.01 |
| 10857 | ENO2/TACC3 ratio | GCST90314670 | 0.01 |
| 10858 | FCRL1/TCL1A ratio | GCST90314795 | 0.01 |
| 10859 | Age completed full time education | Education | UKBB00000013 | 0.01 |
| 10860 | Urinary tryptophan to urinary creatinine ratio | GCST90451748 | 0.01 |
| 10861 | Emotionally unstable personality disorder | FING00000495 | 0.01 |
| 10862 | NADK/S100A11 ratio | GCST90315513 | 0.01 |
| 10863 | Cholesteryl ester levels in LDL | GCST90092884 | 0.01 |
| 10864 | AXIN1/BACH1 ratio | GCST90313400 | 0.01 |
| 10865 | CD274 levels | GCST90468613 | 0.01 |
| 10866 | Total cholesterol levels in LDL | GCST90132686 | 0.01 |
| 10867 | Hearing difficulty | GCST90245774 | 0.01 |
| 10868 | CEACAM8/MMP9 ratio | GCST90314002 | 0.01 |
| 10869 | Suggestive for eosinophilic asthma | FING00001344 | 0.01 |
| 10870 | Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levels | GCST90200145 | 0.01 |
| 10871 | KLRD1/LY9 ratio | GCST90315261 | 0.01 |
| 10872 | Disorders of iron metabolism (PheCode 275.1) | GCST90475743 | 0.01 |
| 10873 | BCR/VASH1 ratio | GCST90313499 | 0.01 |
| 10874 | PLA2G4A/SPINT2 ratio | GCST90315671 | 0.01 |
| 10875 | eGFR in diabetes mellitus (full adjustment) | GCST90624786 | 0.01 |
| 10876 | Other arthritis (FG) | FING00000964 | 0.01 |
| 10877 | Testosterone levels | GCST90483487 | 0.01 |
| 10878 | T1 CAT volume R RightAccumbens | GCST90384109 | 0.01 |
| 10879 | CRIM1/NRP2 ratio | GCST90314261 | 0.01 |
| 10880 | CD27/TGFBR2 ratio | GCST90313776 | 0.01 |
| 10881 | TNFRSF10C levels | GCST90470901 | 0.01 |
| 10882 | DNPH1/PDGFB ratio | GCST90314527 | 0.01 |
| 10883 | chloride (maximum, inv-norm transformed) | GCST90475192 | 0.01 |
| 10884 | Enteropathic arthropathies | FING00000508 | 0.01 |
| 10885 | Basophil percentage of white cells variance | GCST90565688 | 0.01 |
| 10886 | TSHB levels | GCST90470974 | 0.01 |
| 10887 | aparc-DKTatlas rh area postcentral | GCST90003285 | 0.01 |
| 10888 | Physical activity (Total log acceleration 10pm-12am) | GCST90061420 | 0.01 |
| 10889 | Hair colour (natural, before greying): Dark brown (UKB data field 1747_4) | GCST90041839 | 0.01 |
| 10890 | CCL28/PDGFB ratio | GCST90313695 | 0.01 |
| 10891 | PTH levels | GCST90470372 | 0.01 |
| 10892 | Total lipid levels in lipoprotein particles | GCST90092989 | 0.01 |
| 10893 | Hearing difficulty and hearing difficulty with background noise | GCST90245768 | 0.01 |
| 10894 | PLA2G1B/PRSS2 ratio | GCST90315665 | 0.01 |
| 10895 | Qualifications - NVQ or HND or HNC or equivalent | Education | UKBB00000730 | 0.01 |
| 10896 | YOD1 levels | GCST90471090 | 0.01 |
| 10897 | Allergic contact dermatitis | FING00000068 | 0.01 |
| 10898 | Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivity | GCST90302674 | 0.01 |
| 10899 | Cis-4-decenoylcarnitine (C10:1) metabolite level | GCST90615729 | 0.01 |
| 10900 | Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) | GCST90475091 | 0.01 |
| 10901 | Reason for glasses/contact lenses - For 'astigmatism' | Eyesight | UKBB00000733 | 0.01 |
| 10902 | Autoimmune hyperthyroidism | FING00000134 | 0.01 |
| 10903 | ENPP2/TNFRSF11B ratio | GCST90314672 | 0.01 |
| 10904 | Ratio of bis-allylic bonds to double bonds in lipids | GCST90132744 | 0.01 |
| 10905 | Total cholesterol levels | GCST90278644 | 0.01 |
| 10906 | Serum copper levels | GCST90100524 | 0.01 |
| 10907 | NFASC levels | GCST90470031 | 0.01 |
| 10908 | Hemoglobin A1c (HbA1c, mean, inv-norm transformed) | GCST90475094 | 0.01 |
| 10909 | Nervonoylcarnitine (C24:1) levels | GCST90200143 | 0.01 |
| 10910 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T444 | ECGU000444 | 0.01 |
| 10911 | IL15 levels | GCST90469556 | 0.01 |
| 10912 | F-dessert liking (derived food-liking factor) | GCST90094754 | 0.01 |
| 10913 | F-coffee/alcohol liking (derived food-liking factor) | GCST90094737 | 0.01 |
| 10914 | Overall health rating | General health | UKBB00000621 | 0.01 |
| 10915 | Tyrosine levels (UKB data field 23469) | GCST90269566 | 0.01 |
| 10916 | Dermatophytosis / Dermatomycosis (PheCode 110) | GCST90475560 | 0.01 |
| 10917 | RARRES2/ST6GAL1 ratio | GCST90315759 | 0.01 |
| 10918 | GP2/LGALS4 ratio | GCST90314960 | 0.01 |
| 10919 | Fluid intelligence score decline (log-difference score) | GCST90565852 | 0.01 |
| 10920 | Pulmonary embolism | GCST90468148 | 0.01 |
| 10921 | Platelet count | GCST90002402 | 0.01 |
| 10922 | IDP dMRI TBSS ICVF Medial lemniscus R | GCST90004335 | 0.01 |
| 10923 | IL12RB1 levels | GCST90469550 | 0.01 |
| 10924 | Sphingomyelin_33:1_[M+H]1+ levels | GCST90060229 | 0.01 |
| 10925 | SNAP23/SNAP29 ratio | GCST90315855 | 0.01 |
| 10926 | C-reactive protein levels (UKB data field 30710) | GCST90468064 | 0.01 |
| 10927 | Phlebitis and thrombophlebitis (PheCode 451) | GCST90476003 | 0.01 |
| 10928 | Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers) | FING00001067 | 0.01 |
| 10929 | LAIR2 levels | GCST90469729 | 0.01 |
| 10930 | Total lipids in large LDL | GCST90498011 | 0.01 |
| 10931 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T456 | ECGA000456 | 0.01 |
| 10932 | Dermatophytosis (PheCode 110.1) | GCST90475561 | 0.01 |
| 10933 | DCTPP1 levels | GCST90468961 | 0.01 |
| 10934 | Use of dietary supplements (confirmatory factor analysis Factor 13) | GCST90309347 | 0.01 |
| 10935 | aparc-pial rh area postcentral | GCST90003195 | 0.01 |
| 10936 | CLEC1B/DKK1 ratio | GCST90314088 | 0.01 |
| 10937 | Left-hemisphere default mode network to right-hemisphere limbic network white-matter structural connectivity | GCST90302764 | 0.01 |
| 10938 | X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levels | GCST90243619 | 0.01 |
| 10939 | Age at first birth | GCST90000048 | 0.01 |
| 10940 | Physical activity (Total log acceleration 8pm-10pm) | GCST90061419 | 0.01 |
| 10941 | BCR/ITGB1BP2 ratio | GCST90313494 | 0.01 |
| 10942 | Squamous cell carcinoma (PheCode 172.22) | GCST90475583 | 0.01 |
| 10943 | C9 levels | GCST90468505 | 0.01 |
| 10944 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T473 | ECGA000473 | 0.01 |
| 10945 | Cardiorespiratory fitness slope | GCST90093319 | 0.01 |
| 10946 | Cod liking | GCST90094736 | 0.01 |
| 10947 | CPB2 levels | GCST90468840 | 0.01 |
| 10948 | Ulcerative ileocolitis | FING00001392 | 0.01 |
| 10949 | PI3 levels | GCST90470230 | 0.01 |
| 10950 | Type 1 diabetes | GCST90000529 | 0.01 |
| 10951 | Exophthalmic conditions | FING00000526 | 0.01 |
| 10952 | EIF4B/MAP4K5 ratio | GCST90314623 | 0.01 |
| 10953 | Frequency of solarium/sunlamp use | Sun exposure | UKBB00000265 | 0.01 |
| 10954 | Prostate cancer | GCST90428117 | 0.01 |
| 10955 | Pain type(s) experienced in last month - Stomach or abdominal pain | Pain | UKBB00000633 | 0.01 |
| 10956 | Hard cheese liking | GCST90094778 | 0.01 |
| 10957 | DTI autoptx MD ilf r tract | GCST90385235 | 0.01 |
| 10958 | Illnesses of siblings - None of the above (group 1) | Family history | UKBB00000353 | 0.01 |
| 10959 | Body mass index | GCST90502912 | 0.01 |
| 10960 | COPD | FING00000350 | 0.01 |
| 10961 | Long-standing illness, disability or infirmity | General health | UKBB00000409 | 0.01 |
| 10962 | CCN2/EDAR ratio | GCST90313711 | 0.01 |
| 10963 | BLVRB/HBQ1 ratio | GCST90313525 | 0.01 |
| 10964 | DLL1/IL18BP ratio | GCST90314495 | 0.01 |
| 10965 | Patient classification on admission (recoded) - Day case | Summary Administration | UKBB00000636 | 0.01 |
| 10966 | SIGLEC6 levels | GCST90470634 | 0.01 |
| 10967 | CEP43/WASF1 ratio | GCST90314023 | 0.01 |
| 10968 | Total free cholesterol levels | GCST90092988 | 0.01 |
| 10969 | Back pain (PheCode 760) | GCST90476266 | 0.01 |
| 10970 | hemoglobin (mean, inv-norm transformed) | GCST90475376 | 0.01 |
| 10971 | Other demyelinating diseases of the central nervous system | FING00000995 | 0.01 |
| 10972 | PLEKHO1 levels | GCST90470256 | 0.01 |
| 10973 | S100A11/SERPINB8 ratio | GCST90315799 | 0.01 |
| 10974 | TNFRSF19 levels | GCST90088947 | 0.01 |
| 10975 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T443 | ECGU000443 | 0.01 |
| 10976 | AmygNuclei rh volume Lateral-nucleus | GCST90002658 | 0.01 |
| 10977 | LGALS8/TXNDC5 ratio | GCST90315321 | 0.01 |
| 10978 | CD22 levels | GCST90468610 | 0.01 |
| 10979 | Number of sexual partners in opposite-sex sexual behavior | GCST90026480 | 0.01 |
| 10980 | Insulin fold change during an oral glucose tolerance test | GCST90267568 | 0.01 |
| 10981 | Crohn's disease | GCST90446793 | 0.01 |
| 10982 | HEPACAM2 levels | GCST90469445 | 0.01 |
| 10983 | aparc-a2009s lh area G-postcentral | GCST90003324 | 0.01 |
| 10984 | Witnessed sudden violent death | Traumatic events | UKBB00000917 | 0.01 |
| 10985 | Arthropathies in other diseases classified elsewhere | FING00000108 | 0.01 |
| 10986 | Gallstone disease | GCST90128518 | 0.01 |
| 10987 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475456 | 0.01 |
| 10988 | DNAJA2/SCAMP3 ratio | GCST90314507 | 0.01 |
| 10989 | Cigarettes smoked per day (MTAG) | GCST90179151 | 0.01 |
| 10990 | CLEC4D levels | GCST90468773 | 0.01 |
| 10991 | Verbal-numerical reasoning | GCST003498 | 0.01 |
| 10992 | SDC4/SELP ratio | GCST90315817 | 0.01 |
| 10993 | IDP dMRI TBSS OD Genu of corpus callosum | GCST90004404 | 0.01 |
| 10994 | Seborrheic dermatitis (PheCode 690.1) | GCST90476171 | 0.01 |
| 10995 | HEXIM1/TRIAP1 ratio | GCST90315054 | 0.01 |
| 10996 | Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers) | FING00000777 | 0.01 |
| 10997 | Hypertension | GCST90086092 | 0.01 |
| 10998 | MSLN levels | GCST90469948 | 0.01 |
| 10999 | C-reactive protein | Blood biochemistry | UKBB00000113 | 0.01 |
| 11000 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T483 | ECGA000483 | 0.01 |